FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1039011000001103: Erythromycin stearate 250mg tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21445901000001111 Erythromycin stearate 250mg tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21446001000001119 Erythromycin stearate 250mg tablets 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin stearate 250mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Is pack of Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Has active ingredient Erythromycin stearate false Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Has VMP Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Has specific active ingredient Erythromycin stearate true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erythromycin stearate 250mg tablets (Ennogen Pharma Ltd) 100 tablet Is a True Erythromycin stearate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) 100 tablet Is a True Erythromycin stearate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (CST Pharma Ltd) 100 tablet Is a True Erythromycin stearate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) 100 tablet Is a True Erythromycin stearate 250mg tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start